Neurology® Podcast cover image

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Neurology® Podcast

00:00

Innovative Treatment for GCA

This chapter explores the complexities of managing giant cell arteritis (GCA) and the limitations of current steroid therapies. It presents a clinical trial for ubatacitinib, demonstrating its potential to achieve sustained remission in GCA patients more effectively than traditional treatments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app